InsidersTradesSigma
Follow the Defence Therapeutics Inc. share price and the full insider trade history of the company, a listed issuer based in Canada. Shares trade on CA CA, under the authority of SEDI. Market capitalisation: €33.3m. The latest transaction was disclosed on 12 June 2026 (50 - Grant of options). Among the most active insiders: Beaver, John David. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
Defence Therapeutics Inc. is a company focused on developing innovative therapies for cancer treatment and other diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.